When.com Web Search

  1. Ads

    related to: best d3 supplement brand for seniors over 65

Search results

  1. Results From The WOW.Com Content Network
  2. Scientists Reveal New Findings About Older Adults Who Take ...

    www.aol.com/lifestyle/scientists-reveal-findings...

    READ MORE. How much vitamin D do I need? Older adults need about 600 to 800 IU of vitamin D daily, depending on their age. You can get this through a combination of sun exposure and vitamin-D rich ...

  3. Looking For A Vitamin D Supp? Choose One With D3, Not D2 - AOL

    www.aol.com/looking-vitamin-d-supp-choose...

    Vitamin D is essential for bone health and immune function, and deficiency is common. Consoider one of these vitamin D supplements if you're not getting enough.

  4. Taking This Daily Vitamin Could Slash Dementia Risk By 40 ...

    www.aol.com/taking-daily-vitamin-could-slash...

    $20.99 at Amazon. Orange Vitamin D3. Rated at 4.7 stars by over 6,000 happy customers on Amazon, this daily vitamin is a tried-and-true product that's affordable and even offers a refreshing ...

  5. Geritol - Wikipedia

    en.wikipedia.org/wiki/Geritol

    Geritol is a United States trademarked name for various dietary supplements, past and present. [1] Geritol is a brand name for several vitamin complexes plus iron or multimineral products in both liquid form and tablets containing from 9.5 to 18 mg of iron per daily dose. [2] The name conveys a connection with aging, as in "geriatric." The ...

  6. Vitamin D - Wikipedia

    en.wikipedia.org/wiki/Vitamin_D

    For example, CYP11A1, an enzyme chiefly known for its role in steroidogenesis, has been found to hydroxylate vitamin D3 at several positions, including C-20, C-22, and C-23, without cleaving the side chain. The resulting metabolites, such as 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3, act as inverse agonists for RORα and RORγ2.

  7. Centrum (multivitamin) - Wikipedia

    en.wikipedia.org/wiki/Centrum_(multivitamin)

    No statistically significant effects were found for any specific cancers or cancer mortality. The 95% CI of the hazard ratio implied a benefit of between 14% and .2% over placebo. In absolute terms the difference was 1.3 cancer diagnoses, per 1000 years of life (18.3-17 events, respectively). The median follow up time was 11.2 years. [3]